Charles Fong

Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study

I. Vasiliadou, Omar Breik, Holly Baker et al. · Cancers · 2021 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial

M. Vreugdenhil, Charles Fong, Paul Sanghera et al. · Oral Oncology · 2020 · 26 citations · Full text

Medicine, Oncology, Radiation Oncology +8

Implementing Head and Neck Contouring Peer Review without Pathway Delay: The On-demand Approach

Charles Fong, Paul Sanghera, J. Good et al. · Clinical Oncology · 2017 · 20 citations

Medicine, Neck Surgery, Pediatric Care +9

CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

Hisham Mehanna, Piers Gaunt, Anthony Kong et al. · Trials · 2024 · 17 citations · Full text

Medicine, Oncology, Cancer Control +8

Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study

M. Vreugdenhil, Charles Fong, Gulnaz Iqbal et al. · Clinical Oncology · 2021 · 11 citations

Health Professions, Rehabilitation Medicine, Speech-language Pathology +11